Brind.

Young's career timeline includes appointments at TechImmune, service on the Novavax board, and academic/professional ties to GlaxoSmithKline in NYC and Houston.

1 report, 1 independent Updated Aug 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Young's career timeline includes appointments at TechImmune, service on the Novavax board, and academic/professional ties to GlaxoSmithKline in NYC and Houston.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Business WireJames F. Young, Ph.D. Appointed Executive Chairman of TechImmune Executive Chairman of TechImmune, effective August 1, 2025 IRVINE, Calif., August 28, 2025--(BUSINESS WIRE)--Dr. Young brings an extra